Frontiers in Cardiovascular Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管内科 经验分享：11周了，还没分配编辑，撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了，给送审的编辑发邮件询问，也没有回应，也不知道什么情况，焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2023-09-04 ms2000000203298966 来自浙江省

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：心血管;冠心病
经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管内科 经验分享：11周了，还没分配编辑，撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了，给送审的编辑发邮件询问，也没有回应，也不知道什么情况，焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2023-08-22 ms6000001243617632 来自湖北省

大家都推荐审稿人了么，是不是没推就会慢很多

27 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管内科 经验分享：11周了，还没分配编辑，撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了，给送审的编辑发邮件询问，也没有回应，也不知道什么情况，焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2022-06-16 ms3720148795955021

今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！

1181 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管内科 经验分享：11周了，还没分配编辑，撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了，给送审的编辑发邮件询问，也没有回应，也不知道什么情况，焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2021-09-28 隐形的翅膀

审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0
经验分享：分享下自己综述的投稿旅程：
12 Jun 2021：submitted manuscript.
02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor.
02 Sep 2021：Interactive review forum activated.
16 Sep 2021：Submitting Author re-submitted manuscript.
20 Sep 2021：Review of Review Editor 1 finalized.
21 Sep 2021：Review of Review Editor 2 finalized.
27 Sep 2021：Article accepted for publication.
总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错

123 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管内科 经验分享：11周了，还没分配编辑，撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了，给送审的编辑发邮件询问，也没有回应，也不知道什么情况，焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2022-05-19 ms4000000327895144

之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。

278 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管内科 经验分享：11周了，还没分配编辑，撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了，给送审的编辑发邮件询问，也没有回应，也不知道什么情况，焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2023-05-16 ms9000001815965090 来自陕西省

请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？

27 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管内科 经验分享：11周了，还没分配编辑，撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了，给送审的编辑发邮件询问，也没有回应，也不知道什么情况，焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2023-04-20 ms8000001488135201 来自陕西省

审稿速度:24.0 | 投稿命中率:5.0
偏重的研究方向：心血管内科
经验分享：11周了，还没分配编辑，撤了撤了

32 0

[GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管内科 经验分享：11周了，还没分配编辑，撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了，给送审的编辑发邮件询问，也没有回应，也不知道什么情况，焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2022-04-09 ms3720148795955021

independent review 快2个月了，给送审的编辑发邮件询问，也没有回应，也不知道什么情况，焦急的上蹿下跳的

110 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管内科 经验分享：11周了，还没分配编辑，撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了，给送审的编辑发邮件询问，也没有回应，也不知道什么情况，焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2022-11-01 ms9000000439591833

偏重的研究方向：心血管影像诊断
经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。

152 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家，审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes，是会有什么其他审查流程吗?需要提交原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管内科 经验分享：11周了，还没分配编辑，撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了，给送审的编辑发邮件询问，也没有回应，也不知道什么情况，焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097849, encodeId=7c02209e84970, content=偏重的研究方向：心血管影像诊断 经验分享：速度好慢呀。 10月25投的，现在还在第一步initial validation,不知道是什么原因。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995454406, createdName=ms9000000439591833, createdTime=Tue Nov 01 15:39:03 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179982, encodeId=8c3311e9982ac, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0 偏重的研究方向：心脏再生;心外科 经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/39bba88f7f0f4b478c251e6c799cdc2b/8db00714d0714cef96cf46cbe860fe6e.png, createdBy=fd4c5571435, createdName=黄伟民, createdTime=Mon Jan 03 12:14:53 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2022-01-03 黄伟民

审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2250.0
偏重的研究方向：心脏再生;心外科
经验分享：期刊今年发文量2391是去年363的近8倍，2021最后一天最新中科院预警名单中，frontiers系列上了3个，大家注意，谨慎投此刊，小心步Medcine的后尘!

218 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

科研工具

写作工具

其他工具

平台业务解决方案

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务